Patients in Europe Wait an Average 531 Days to Get New Medicines, Says Report
Due to a combination of confounding factors in the regulatory system and the market, patients in Europe wait an average of 531 days to access new medicines, according to three new reports published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) this week.
Source: Drug Industry Daily